Altered risky decision making in patients with early non-affective psychosis

Autor: Chang Wc, Chen Eyh, Siu Cmw, Chong Csy, Chan Skw, Lo Tl, Lee Tmc, Lee Emh, Sun Yn, Hui Clm, Luk Msk

Publikováno v: European archives of psychiatry and clinical neuroscience. 271(4)

Abnormal risky decision making may represent an important factor contributing to functional impairment in psychotic disorders. Previous research revealed impaired decision making under risk in patients with chronic schizophrenia. However, risky decis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3cecb54ab322d1ea943163b14c20548
https://pubmed.ncbi.nlm.nih.gov/30806772

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Educational needs and career development of young epileptologists in Italy.

Autor: Spagnoli C; Child Neuropsychiatry Unit, Pediatric Department, Santa Maria Nuova Hospital, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Duca M; Child Neuropsychiatry Unit, Ospedale Civile di Macerata, Macerata, Italy., Pelliccia V; 'Claudio Munari' Epilepsy Surgery Centre, Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy., Lanzone J; Neurorehabilitation Department of the Milano Institute, Istituti Clinici Scientifici Maugeri IRCCS, Milan, Italy., Masnada S; Child Neurology Unit, Buzzi Children's Hospital, Milan, Italy., Chiarello D; 'Claudio Munari' Epilepsy Surgery Centre, Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy., Barco TL; Child Neuropsychiatry Department, Epilepsy Center, C. Poma Hospital, Mantova, Italy., Dono F; Department of Neuroscience, Imaging and Clinical Science, 'G. D'Annunzio' University of Chieti-Pescara, Chieti, Italy., Nucera B; Department of Neurology, Hospital of Merano (SABES-ASDAA), Merano, Italy.; Paracelsus Medical University, Salzburg, Austria.

Publikováno v: Epilepsia open [Epilepsia Open] 2024 Apr; Vol. 9 (2), pp. 613-625. Date of Electronic Publication: 2024 Feb 22.

Candida auris uses metabolic strategies to escape and kill macrophages while avoiding robust activation of the NLRP3 inflammasome response.

Autor: Weerasinghe H; Infection Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia., Simm C; Infection Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia., Djajawi TM; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia., Tedja I; Infection Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia., Lo TL; Infection Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia., Simpson DS; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; The Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia., Shasha D; Infectious Diseases Unit, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mizrahi N; Infectious Diseases Unit, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel., Olivier FAB; Infection Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Speir M; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia., Lawlor KE; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia., Ben-Ami R; Infectious Diseases Unit, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Traven A; Infection Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia. Electronic address: ana.traven@monash.edu.

Publikováno v: Cell reports [Cell Rep] 2023 May 30; Vol. 42 (5), pp. 112522. Date of Electronic Publication: 2023 May 18.